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Sirt1 is a NAD-dependent class III deacetylase that functions as a cellular energy sensor. In 
addition to its well-characterized effects in peripheral tissues, emerging evidence suggests that 
neuronal Sirt1 activity plays a role in the central regulation of energy balance and glucose 
metabolism. In this study we generated mice expressing an enzymatically inactive form (N-
MUT) or wild-type SIRT1 (N-OX) in mature neurons.  Both N-OX male and female mice 
showed impaired glucose tolerance, and N-MUT female, but not male, mice showed improved 
glucose tolerance compared to WT littermates. Furthermore, all mice showed improved glucose 
tolerance with caloric restriction (CR), but the N-OX mice showed the greatest change and now 
showed better glucose tolerance than their littermates. At the reproductive level, N-OX females 
showed impaired estrous cycles, with increased cycle length and more time in estrus.  LH and 
progesterone surges were absent on the evening of proestrus in the N-OX mice suggesting a 
defect in spontaneous ovulation, which was confirmed by the ovarian histology with a reduced 
number of corpora lutea. Despite this defect, the mice were still fertile when mated to wild-type 
mice on the day of pro-estrus indicating that the mice can respond to normal pheromonal or 
environmental cues. When subjected to CR, the N-OX mice went into diestrus arrest earlier than 
their littermates. Together, these results suggested that the overexpression of SIRT1 rendered the 
mice more sensitive to the metabolic improvements and suppression of reproductive cycles by 
CR, which was independent of circadian rhythms. 
INTRODUCTION: 
Sirtuin 1 (Sirt1) was first identified as a mammalian homolog of the yeast Silent Information 
Regulator 2 (Sir2) protein, which is essential for lifespan extension due to caloric restriction. The 
sirtuins are class III histone deacetylases that require NAD+ for enzyme activity1 and these 
enzymes function as cellular energy sensors sensitive to the intracellular NAD+/NADH ratio. 
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Sirt1 is activated during fasting to increase fatty acid oxidation and gluconeogenesis, and 
suppress insulin secretion, insulin action, and adipogenesis2-4. Conversely, SIRT1 is reduced in 
adipose tissue by over-nutrition in both mouse models and human obesity, and also in many 
brain regions5-8. Consequently, global transgenic overexpression improves glucose tolerance and 
insulin sensitivity even on a low fat diet due to increased brown adipose tissue (BAT) activity, 
enhanced β3 adrenergic stimulation and reduced inflammation 9-11. The global knockout is 
difficult to interpret as most mice die in utero or perinatally12-14, and those that survive on an 
outbred background are runted14. The global inactivation of the acetylase activity by deletion of 
exon 4 leads to a similar phenotype with embryonic lethality but the few surviving animals 
showed higher triglycerides, higher fatty acid release from adipose tissue and greater hepatic 
steatosis on a high fat diet15,16. Similarly, introduction of a point mutation (H355Y) that 
inactivates the enzyme activity causes runting, elevated oxygen consumption and male 
infertility17, and increased the susceptibility to HFD-induced metabolic dysfunction18.  SIRT1 
has also been reported to have tissue specific effects. Forced reduction of Sirt1 in white adipose 
tissue (WAT) by anti-sense oligonucleotides or conditional knockout reduced body weight and 
WAT weight, but increased macrophage infiltration, while overexpression prevents these 
effects19. Loss of Sirt1 in skeletal muscle reduces insulin sensitivity during caloric restriction20. 
Deletion in hepatocytes causes increased hepatic glucose production, fasting hyperglycemia, 
greater fasting-induced steatosis, and the development of late-onset obesity16,21-23. A transgenic 
overexpressing line that uses the entire Sirt1 gene did not mimic intermittent fasting, despite 
enhancing brown adipose tissue function and protecting against HFD-induced glucose 
intolerance 10,11,24-26. Conflicting results have been obtained at the reproductive level. One study 
reported that the few surviving male mice from the global knockout studies are infertile as are 
the majority of female mice14, but another study found that mice could be fertile27,28.  Sirt1 is 
expressed in spermatogonia and has been implicated in germ cell development in males29,30. In 
the ovary, SIRT1 is expressed in large follicles particularly in the oocyte and granulosa cells. 
Loss of SIRT1 causes small ovaries with early stage follicular development but no evidence of 
ovulation14,31. SIRT1 modulates both androgen receptor and estrogen receptor-alpha function 
that may underlie some of the reproductive effects32-35. Sirt1 thus has beneficial effects in 
multiple tissues to ameliorate insulin resistance and support reproduction.   
SIRT1 also pays a role in the central nervous system but the results are less clear. Many 
studies have focused on the role of SIRT1 to prevent neuronal injury in ischemic stroke, 
alzheimers, brain injury and other models of neurodegeneration, potentially by reducing 
neuroinflammation36-38. SIRT1 also modulates cognitive function, synaptic plasticity and 
learning39. Brain specific deletion of Sirt1 using Nestin-cre decreases monoamine oxidase 
activity, increases serotonin, and decreases anxiety and depressive-like behavior40,41. As in the 
periphery, SIRT1 expression and activity increases in the hypothalamus with fasting to regulate 
food intake and energy expenditure42-44. Some of these effects may be mediated by different 
neuronal populations as deletion of Sirt1 in pro-opiomelanocortin (POMC) neurons decreases 
energy expenditure and increases susceptibility to diet-induced obesity (DIO) in mice45, but 
deletion of Sirt1 in Agouti-related peptide (AgRP) neurons has the opposite effect and decreases 
food intake and body weight46,47. Mice lacking Sirt1 in Sf1 expressing neurons have increased 
susceptibility to diet-induced obesity and insulin resistance similar to the Pomc neuron KO, 
primarily due to decreased energy expenditure and skeletal muscle insulin sensitivity, but the 
mice are fertile, and transgenic overexpression prevents these effects48. Thus, it appears that Sirt1 
may play distinctive and sometimes even opposing roles in energy balance and reproduction 
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through different neuronal populations. Interpretation of the studies is complicated by the 
different approaches used to delete the gene.  Some studies use deletion of exon 4, which 
encodes the de-acetylase domain, to create a mutant protein lacking enzyme activity, but other 
studies delete exons 2-3 that introduces a premature termination codon so no protein is produced.  
The widespread expression of SIRT1 in both the periphery and CNS makes it difficult to assign a 
function for SIRT1 in a particular process, therefore we have chosen to create neuron-specific 
genetic modifications using transgenic cre recombinase that is expressed in a wide range of 
mature neurons.  Using this approach, we recently reported that loss of SIRT1 enzymatic activity 
in neurons in male mice reduced fasting and glucose-stimulated insulin levels while maintaining 
normoglycemia suggesting increased insulin sensitivity37. Here we characterized both male and 
female mice expressing this enzymatically dead SIRT1 mutant, or conversely conditionally 
overexpressing the wild-type SIRT1 protein, in mature neurons using synapsin-cre to distinguish 
peripheral from central effects on metabolism and reproduction.  
METHODS: 
Animals:  
Mice having cre recombinase expression under control of the neuron-specific Syntaxin1 
promoter (Syn-cre) 49 were mated with mice containing an exon 4 floxed Sirt1 allele or a floxed-
STOP Sirt1 allele50. Expression of cre deletes exon 4 of SIRT1 that encodes the acetylase 
domain thus creating a functionally inactive mutant (referred to as N-MUT) from the floxed 
allele, or causes overexpression of wild-type SIRT1 by deletion of the transcriptional STOP 
sequence from the flox-STOP allele (referred to as N-OX). The cre driver was maintained on the 
female side as the Syn-cre transgene expresses in the testis51.  Syn-cre mice express the cre 
transgene as early as e12.5 in differentiated neurons throughout the brain49. Homozygous 
flox/cre- and heterozygous flox/cre- littermates from either the MUT or OX breeding pairs were 
used as wild-type control (WT).   In most experiments no statistical difference was observed 
between the WT control mice from the N-MUT or N-OX breeding pairs, so the data were 
combined into a single WT group.  Occasionally statistically significant differences were 
observed between the control groups, in which case the data were analyzed against each separate 
control groups. Mice were housed in a 12-h light, 12-h dark cycle. Body weights were recorded 
weekly out to 90 days of age for both genders.  Males and females had access to standard chow 
and water ad libitum.  Mouse procedures conformed to the Guide for Care and Use of Laboratory 
Animals of the US National Institutes of Health and were approved by the Animal Subjects 
Committee of UCSD. 
Caloric Restriction:  
At 12 weeks of age, food intake was measured on cohorts of female and male mice for 2 weeks 
to assess ad libitum food intake.  For the graded caloric restriction, mice were provided with 90% 
of prior food intake for week 1, then 80% for week 2, 70% for week 3, then maintained at 60% 
of original intake for weeks 4-6. Body weight was measured weekly. The study was divided into 
four phases: before, stage 1 (weeks 1 & 2, 10-20% restriction), stage 2 (weeks 3 & 4, 30-40% 
restriction), and stage 3 (weeks 5 & 6, 40% restriction). Estrous cycles were monitored in female 
mice by vaginal cytology for the entire 8 weeks. A cycle was defined as a day of di or metestrus, 
followed by a day of proestrus, then a day of estrus. The length of the cycle was defined as the 
number of days between successive days of proestrus in normal DPE cycles 
Puberty onset and fertility assessment:  
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Male and female pups were weaned at 21 days of age. Female pups were checked for vaginal 
opening as a sign of onset of puberty, and monitored for first estrous. For fertility assessment, N-
MUT, N-OX or WT female mice were paired on the day of proestrus with known WT male 
breeders. The number of days to observable vaginal plugs, the number days to the first litter and 
average number of pups born were recorded.   
Tissue collection and histology:  
Testes, ovaries, brain, pituitaries and other tissues were harvested at sacrifice for both histology 
and RNA extraction.  Testes were fixed in Bouin's solution for 6 hours and ovaries in formalin 
for 24 hours followed by washing in 70% ethanol. Paraffin embedded sections (5 µm) were cut, 
dewaxed, and stained with hematoxylin and eosin. Follicle number and stage, and corpora lutea 
number were counted on 3-5 sections from ovaries from 4-5 mice per group and are presented as 
mean number per ovary52.  Follicle stages were defined as follows: 1o as having a single layer of 
cuboidal granulosa cells (GCs), 2o as having 2 or more layers of cuboidal GCs but no antrum, 
early antral as having small patches of clear space between GCs, antral as having clearly defined 
antrum, atretic as having irregular oocyte morphology. Ovarian sections examined were 
separated by 50 µm. Images were scanned using Aperio ImageScope and analyzed using the 
Imagescope software (Leica, Buffalo Grove, IL).  
Gene expression:  
Total RNA was extracted from the tissues using RNAbee (Tel-Test Inc. Friendswood, TX) 
following the manufacturer’s instructions. First-strand cDNA was synthesized using a High 
Capacity cDNA synthesis kit (Applied Biosystems, Waltham, MA). Targeted quantitative PCR 
(QPCR) assays were run in 20 µL triplicate reactions on a MJ Research Chromo4 instrument 
using iTaq SYBR Green supermix (Bio-Rad, Hercules, CA). For gene expression assays using 7 
nl microfluidic arrays (Fluidigm, San Francisco, CA), mRNA was extracted using RNAbee as 
before, but it was further purified using RNA purification kits from QIAGEN (Germantown, 
MD) or Macherey-Nagel (Bethlehem, PA), according to manufacturer’s instructions. Custom 
QPCR primers for a panel of targets were designed and synthesized by Fluidigm for their 
BioMark™ HD System. Gene expression levels were calculated after normalization to the 
housekeeping gene, m36B4 or Gapdh using the 2-∆∆Ct method and expressed as relative mRNA 
levels compared to the control. Primers are listed in Supplementary Table 153. 
Gonadotropin measurements:  
Blood was collected from the tail vein of males and from females at diestrus and proestrus and 
plasma prepared. Plasma LH and FSH levels were measured by Luminex assay (catalog number 
RPT86K; Millipore Corp, Bedford, MA). Sensitivity of the assay is as follows LH: 4.9 pg/mL 
and FSH: 47.7 pg/mL with an intra-assay coefficient of variation of 15%. For the GnRH 
stimulation test, tail vein blood was collected before and 10 minutes after ip injection of 1 µg/kg 
GnRH, and gonadotropins were measured. 
Intraperitoneal glucose tolerance and insulin tolerance tests:  
Mice were subjected to i.p. glucose- and insulin-tolerance tests. Mice were fasted for 6 hours and 
then injected i.p. with glucose (1 g/kg body weight) or insulin (0.4 U/kg body weight). Tail vein 
blood glucose was measured at 0, 15, 30, 45, 60, 90, and 120 minutes after injection using a 
glucose meter (OneTouch Ultra; Bayer Healthcare, Tarrytown, NY). GTT and ITT assays were 
performed for mice on normal chow and during the last week of 40% food restriction. 
Insulin, leptin and steroid measurements:  
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Animals were fasted for 6 h. Glucose was measured with a glucose meter, blood drawn from the 
tail vein and plasma obtained. Fasting insulin and Leptin were measured using the Mouse 
Metabolic Kit from Meso Scale Discovery, catalog number K15124C-2. Sensitivity of the assay 
was as follows: Leptin: 43 pg/ml, Insulin: 15 pg/ml; CV 6% and 12% respectively. Estrogen, 
progesterone and testosterone were measured using a Custom Steroid Hormone Panel Kit (MSD) 
Sensitivity of the assay was as follows: estradiol 5 pg/ml; progesterone 70 pg/ml; testosterone 20 
pg/ml; CV 7%, 15% and 22% respectively. 
Metabolic assessment:  
Six mice per group (WT and N-OX), matched for body weight, were individually housed in a 12-
chamber Clinical Laboratory Animal Monitoring System (CLAMS) with controlled temperature, 
light and feeding (Columbus Instruments, Columbus, OH). Oxygen uptake, carbon dioxide 
output, respiratory exchange ratio (RER), horizontal and vertical ambulatory movement, feeding 
and drinking per 13 minute intervals were measured over a 3-day period. Data from the first 12 h 
during day 1 acclimation were excluded from the analysis. 
Circadian activity:  
Female and male mice were raised in a LD 12:12 photoperiod until 3 months of age. Thereafter, 
mice were singly housed in standard shoebox cages equipped with running wheels (13 cm 
diameter). Cages were maintained in light-tight secondary enclosures with programmable 
fluorescent lighting for a three-phase assessment of circadian entrainment and free-running 
behavior conducted over approximately 6 weeks.  Initially, entrained behavior of each mouse 
was assessed over two weeks in LD 12:12.  Thereafter, monitoring continued for an additional 
two weeks in a skeleton photoperiods consisting of two 1 h light pulses coinciding with the first 
and last hours of the 12 h light phase.  This protocol removes potential masking effects of bright 
light on locomotor activity.  Finally, endogenous circadian rhythmicity was assessed under 
constant darkness (DD) over 7-10 days.   A total of 48 mice were assessed in four cohorts. 
 Wheel turns were recorded and compiled into 6-min bins.  Data were analyzed offline 
using the Clocklab (Actimetrics; Wilmette, IL) suite of Matlab (Mathworks; Natick, MA) 
plugins.  For each animal, the following variables were calculated in LD and skeleton 
photoperiods over final 7-day spans of each photoperiod condition. The proper phasing of 
activity was assessed by calculating the timing of activity onset and offset as defined as the first 
and last time that the 7-day average activity profile rose above and below the daily mean, 
respectively.  From these data were derived the phase angle of entrainment and the duration of 
elevated nighttime activity. Disruption of circadian timing was additionally assessed by 
calculating the proportion of activity intruding into the daytime (central 8 h of the light phase or 
skeleton daytime).  Rhythm robustness was assessed by calculating the maximum amplitude of 
the chi-square periodogram. In the first 7 days of DD, free-running period was estimated a) as 
the value with the highest amplitude in the chi-square periodogram and b) the best-fit linear 
regression line through identified activity onsets. These methods yielded comparable estimates 
and only the former is reported here. Individually identified activity onsets were additionally 
used to determine the cycle-to-cycle variability in free-running activity onset. In all phases, total 
amount of wheel-running activity without respect to its timing was also assessed. All data were 
analyzed with 4-way ANOVA with cohort, strain (OX vs MUT), Cre genotype (Cre+ or Cre-) 
and sex (M or F) as between subjects factors.  For phenotype screening, alpha was set initially at 
0.05 without correction for multiple comparisons. 
Statistical analysis:  
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Data were analyzed by ANOVA or Students t-test as appropriate using Graph Pad Prism 
(GraphPad, La Jolla, CA) or in R. Pairwise comparisons were performed using Tukey post hoc 
tests following the ANOVA. Results were expressed as Mean+/-Standard Error and considered 
significant with p<0.05. Supplementary data is available online. 53 
RESULTS:   
Overexpression of SIRT1 in neurons caused glucose intolerance.  
To test the role of neuronal SIRT1 in metabolic and reproductive regulation, we generated mice 
expressing an enzymatically inactive form of SIRT1 (N-MUT) 37 or overexpressing wild-type 
SIRT1 (N-OX) in neurons. Assessment of Sirt1 mRNA expression in whole brains from N-OX 
mice indicated that the gene is overexpressed approximately 2.5-fold (Supplementary Figure 
S1A53).  The body weights of male mice indicated a significant difference with genotype over the 
first 3 months although no significant difference was observed at 8-9 months of age (Fig. 1A), 
and the female mice did not differ appreciably in body weight (Fig. 1B). Food intake did not 
differ in male mice, but the female N-MUT mice ate significantly more (Fig. 1G and H) despite 
having equivalent body weight. The male N-OX mice were significantly glucose intolerant (Fig. 
1C) unlike the N-MUT mice as we have previously published.  Consistent with the male mice, 
the female N-OX mice also showed glucose intolerance, but the N-MUT mice showed 
significantly improved glucose tolerance compared to WT controls (Fig. 1D). Neither the N-
MUT nor N-OX groups showed altered insulin tolerance in male mice, but the female N-MUT 
mice were significantly more insulin sensitive than WT or N-OX littermates (Fig. 1E and F). 
Fasting blood glucose and insulin levels and homeostatic model of assessment of insulin 
resistance (HOMA-IR) were comparable between the groups and sexes (Fig. 1I to L, 
Supplementary Figure S1B53) but leptin levels were significantly lower in N-OX mice for both 
sexes (Fig. 1M and N). 
Overexpression of SIRT1 impaired estrous cycles.   
Neither N-MUT nor N-OX female mice differed in the day of vaginal opening (Fig. 2A) but the 
N-OX mice reached first estrous slightly earlier (Fig. 2B), indicating that all genotypes went 
through puberty normally.  Assessment of the number of estrous cycles over 6 weeks after the 
onset of estrous cycles showed that N-OX mice had fewer cycles (Fig. 2C), and analysis of cycle 
length indicated that N-OX mice tended to have a slightly longer mean cycle length (Fig. 2D, 6.6 
days for N-MUT, 6.5 days for WT, and 7.8 days for N-OX) with more extended cycles (Fig. 2E). 
The N-OX mice had significantly more days of estrus and fewer days of diestrus (Fig. 2F).  
Representative cyclegrams are given in Supplementary Figure 253.  No differences in follicle 
stimulating hormone (FSH) were observed in N-OX mice at diestrus, the morning or evening of 
proestrus, or on estrus, but the WT mice showed the expected higher levels during late proestrus 
and estrus (Fig. 2G).  Luteinizing hormone (LH) levels were elevated at diestrus in N-MUT mice 
but no differences were observed in early proestrus or on estrus (Fig. 2H).  LH levels during late 
proestrus showed LH surges in N-MUT (2/8) and WT (8/16) mice but no surges were observed 
in N-OX mice (Fig. 2I).  Measurement of progesterone levels confirmed that N-OX mice had not 
ovulated compared to WT mice (Fig. 2J).  These results suggested that spontaneous LH surges 
might be impaired in the N-OX mice, so we tested fertility directly by pairing female mice on 
proestrus with known male WT breeders.  The number of days until the observation of vaginal 
plugs, the number of days until first litter and the litter size did not show a difference with 
genotype (Fig. 1K), indicating the mice were fertile and could ovulate given normal 
environmental cues.  Comparison of ovarian histology (Fig. 3A) showed that N-OX ovaries were 
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smaller (Fig. 3B) and did not show a difference in follicle development (Fig. 3C), but corpora 
lutea were significantly reduced in the N-OX mice consistent with the decreased LH surges and 
progesterone levels (Fig. 3D). Male mice were not studied reproductively as the synapsin-cre 
expresses in the testis51. 
Mice overexpressing SIRT1 in neurons were more sensitive to improvements in glucose tolerance 
and estrous cycle arrest due to caloric restriction.  
We then tested whether neuronal SIRT1 might alter the response to caloric restriction (CR).  To 
avoid the induction of an adrenal stress response due to a rapid reduction in food intake, we used 
a gradual reduction of food intake over four weeks, 10% per week, then maintained the mice for 
a further 2 weeks at 40% caloric restriction.  Assessment of glucose tolerance during the last 
week showed that the N-OX mice had improved glucose tolerance (Fig. 4A).  Insulin levels were 
higher in WT and N-OX mice during the initial stage of CR consistent with fasting-induced 
insulin-resistance, but then returned to normal (Fig. 4B).  In contrast, leptin levels decreased 
progressively during CR (Fig. 4C) and the N-OX mice showed consistently lower leptin levels as 
we had seen earlier (Fig. 1M and N). 
Estrous cycles were assessed in the female mice during the entire period of caloric 
restriction.  N-MUT mice showed the same response as WT mice with a gradual increase in the 
days of diestrus and a decrease in the days at proestrus and estrus (Fig. 5A).  In contrast, the N-
OX mice had fewer days at diestrus before CR, did not respond to the 10-20% restriction, but 
showed a steep increase in the days of diestrus during the 30-40% restriction such that all mice 
were in permanent diestrus by 40% CR.  This was confirmed by determining the relative 
frequency of diestrus arrest at each CR stage for each genotype (Supplementary Figure S3A53). 
The WT and N-MUT mice had the highest frequency of arrest at 40% CR but the N-OX mice 
had the highest frequency of arrest at 20-30% CR. Unexpectedly, we did not observe a 
significant decrease in LH during CR in any genotype (Fig. 5B), but we did observed an increase 
in FSH even at the lowest level of CR (Fig. 5C). Interestingly, this response was sexually 
dimorphic as FSH levels decreased in male mice on CR, but LH levels did not change 
(Supplementary Figure S3B53). Inspection of ovarian histology at sacrifice showed that all mice 
had ceased cycling as no corpora lutea were observed (Supplementary Figure S453). Steroid 
hormone levels were measured at sacrifice. Estrogen levels were slightly higher with CR but 
were significantly lower in WT mice than N-MUT and N-OX mice (Fig. 5D).  Progesterone 
levels increased during CR (Fig. 5E) and testosterone levels showed an increase with CR but also 
a genotype effect with N-MUT mice having significantly higher levels of testosterone (Fig. 5F). 
Altered hypothalamic gene expression in mice on caloric restriction.   
RNA was extracted from hypothalami and pituitaries from female mice sacrificed at the end of 
CR. The N-OX mice showed approximately 2-fold overexpression of Sirt1 by QPCR (Fig. 6A) 
as observed before (Fig. 1).  The neuropeptide Y (Npy), pro-opiomelanocortin (Pomc) and 
agouti-related peptide genes (Agrp) that control food intake and energy expenditure were 
increased in the N-OX mice, but the cocaine and amphetamine-regulated transcript (Cart) was 
unchanged (Fig. 6A).  The reproductive neuropeptides gonadotropin-releasing hormone 1 
(Gnrh1), and the RF-amide related peptide 3 (RFRP3, GnIH) precursor gene (Npvf) were 
significantly altered but the kisspeptin gene (Kiss1) was unchanged (Fig. 6A).  Neuropeptide 
receptor gene expression did not change with genotype (Supplementary Figure S3C53).  The 
same alterations in hypothalamic gene expression were not seen in male mice (Supplementary 
Figure S553).  Assessment of pituitary gene expression in female mice indicated a 3-fold increase 
in Fshb gene expression in N-OX mice, an increase in the glycoprotein hormone alpha gene 
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(Cga) in the N-MUT mice, and decreases in growth hormone (Gh) and pituitary adenylate-
cyclase activating peptide (Adcyap1) gene expression in N-MUT mice (Fig. 6B). 
Mice overexpressing SIRT1 showed altered activity during the dark phase.  
As the N-OX mice were glucose intolerant, we subjected N-OX and WT mice to a metabolic 
assessment with continuous monitoring over 3 days.  The N-OX mice showed stronger diurnal 
changes in ambulatory and rearing activity (Fig. 7A & B).  The onset of activity at the start of the 
dark phase was similar but the N-OX mice showed greater activity and sustained that activity 
throughout the entire dark phase whereas the WT mice reduced activity in anticipation of the 
light phase.  The difference in average activity between the dark and light phase was also 
increased (Supplementary Figure S653).  There was no significant difference in body weight 
between genotypes at the end of the assessment.  Oxygen consumption was also altered with 
lower consumption at the start of dark phase but higher consumption at the end of the dark phase 
(Fig. 7C) and the respiratory exchange ratio showed a genotype effect with greater lipid 
oxidative metabolism during the light phase in the N-OX mice consistent with greater fasting 
(Fig. 7D).  Food intake showed a diurnal variation but no genotype effect, whereas water intake 
showed a weak genotype effect (Fig. 7E & F).  Heat production and cage temperature showed 
the expected diurnal variation but no genotype effect (Fig. 7G & H).  
Mice lacking or overexpressing SIRT1 in neurons did not show altered circadian activity.   
SIRT1 has been implicated in the regulation of the central circadian clock via de-acetylation of 
PGC-1α. 54  Therefore we initially assessed activity during regular 12h/12h light/dark (LD) 
cycles, then 2h/22h skeleton periods, then 24h continual darkness (DD).  In LD, female mice 
showed more robust rhythms (p<0.05) than male mice (Supplementary Table 253) and showed 
higher total activity counts and average counts (p<0.001). Mice initiated wheel-running shortly 
after lights off according to the expected nocturnal pattern, and showed the same period and 
activity onset and offset. The sex difference in rhythm robustness, average counts and total 
counts persisted in the skeleton photoperiods (p<0.05, 0.01 and 0.01 respectively). There were 
small genotype differences in rhythm robustness, 8h daytime counts, activity onset, and activity 
period but none reached significance. In DD, the period showed a strain effect (p<0.05) with all 
MUT strain mice having slightly shorter period, and rhythm robustness showed a genotype effect 
(p<0.05) with the MUT genotype having greater robustness. In summary, SIRT1 overexpressing 
and mutant mice generated species-typical circadian locomotor activity rhythms, with the major 
difference being female mice showed greater activity and more robust rhythms.  
DISCUSSION 
Previously, loss of SIRT1 enzyme activity in neurons did not alter glucose metabolism in male 
mice but increased insulin sensitivity in the brain and periphery, and partially protected mice 
from high-fat diet induced obesity37.  Here we studied the same neuronal SIRT1 mutant lacking 
enzyme activity (N-MUT), but also studied the effect of overexpression of wild-type SIRT1 (N-
OX) in neurons.  In male mice we observed that the N-MUT did not alter glucose tolerance as 
before, but we did observe decreased glucose tolerance with overexpression of SIRT1 (N-OX), 
which is consistent with the previous report on the N-MUT mice.  In contrast, female mice 
showed an improvement in glucose tolerance in the N-MUT transgenic mouse, and an 
impairment in the N-OX overexpressing mouse.  Unlike the male mice, the female N-MUT mice 
showed a slight increase in insulin sensitivity by ITT but fasting blood glucose and insulin were 
not changed, and consequently HOMA-IR was not significantly different. As SIRT1 has been 
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implicated in the response to food restriction, the mice were challenged with a gradual but 
progressive caloric restriction down to 60% of their normal food intake over 6 weeks.  All mice, 
male and female showed improved glucose tolerance, and the N-OX mice showed better glucose 
tolerance than their littermates after CR, instead of worse glucose tolerance as had been seen for 
mice on ad libitum normal chow. This suggested that the overexpression of SIRT1 rendered the 
mice more sensitive to the metabolic effects of caloric restriction.  
In a previous study, deletion of SIRT1 enzyme activity (∆exon 4) in neurons, astrocytes, glia 
and the pituitary using nestin-cre disrupts the GH-IGF1 axis causing runting43.  Young mice 
displayed normal glucose tolerance but older mice were glucose intolerant. Caloric restriction 
improved glucose tolerance in both wild-type and the total brain KO mice indicating that SIRT1 
enzyme activity was not required for the metabolic response to CR43.   These KO mice showed 
increased physical activity in a wheel-running experiment but did not subsequently respond to 
CR. A subsequent study showed that this activity difference correlated with lower anxiety and 
increased exploratory drive due to decreased monoamine oxidase activity and increased 
serotonin and norepinephrine levels41. These studies are confounded however by the observation 
that SIRT1 is essential for neural fate determination in neural stem cells and could alter the final 
balance of neuronal, astrocyte and oligodendrocyte populations, including Npy/AgRP and Pomc 
neurons55-58. More focused deletion in specific neuronal populations has produced conflicting 
results. Deletion of Sirt1 in either Pomc or Sf1 neurons decreases energy expenditure and 
increases susceptibility to diet-induced obesity but has no effect for mice on normal chow45,48, 
but deletion in Agrp neurons has the opposite effect and decreases food intake and body 
weight46,47. Transgenic SIRT1 overexpression in Pomc or Sf1 neurons increased energy 
expenditure, increased insulin sensitivity and reduced body weight. The opposite effect was 
observed when Sirt1 was overexpressed in the mouse forebrain using the CMKIIα promoter, 
which caused decreased energy expenditure, decreased physical activity, obesity and glucose 
intolerance59. We did not see an effect on body weight in either the female N-OX or N-MUT 
mice on normal chow, similar to the Pomc or Sf1 neuron knockouts, but we observed an increase 
in physical activity and VO2 in female N-OX, and our mice were glucose intolerant. In addition, 
overexpression of SIRT1 using the mouse prion Prp promoter caused an enhanced response to 
caloric restriction as measured by physical activity counts44 in agreement with our study. This 
confirms the ability of SIRT1 to mediate the central metabolic effects of CR but overexpression 
of SIRT1 alone may not be sufficient to mimic CR. 
At the reproductive level, complete loss of Sirt1 results in hypogonadotropic hypogonadism 
due to failure of Gnrh neurons to migrate28. Female pubertal development was normal in the N-
OX and N-MUT mice.  Overexpression of SIRT1 impaired estrous cycles, and increased the 
number of days in estrus, perhaps because the N-OX mice did not show the normal increase in 
FSH during estrus to start the next follicular cycle.  LH and progesterone surges were absent on 
the evening of proestrus in the N-OX mice consistent with a defect in ovulation, which was 
confirmed by the ovarian histology that showed a reduced number of corpora lutea.  This agrees 
with a study reporting that the SIRT1 activator SRT1720 reduced ovary size and reduced the 
number of corpora lutea60. Despite these defects, the mice were still fertile when mated to wild-
type mice on the day of pro-estrus indicating that the mice can respond to normal pheromonal or 
environmental cues. When subjected to CR, the N-OX mice went into diestrus arrest earlier than 
their littermates suggesting that the overexpression of SIRT1 also renders mice more sensitive to 
the suppression of reproductive cycles. Unlike other fasting studies, LH levels did not decrease 
with the gradual CR indicating that we avoided an adrenal stress response which is known to 
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suppress LH.  We noticed a consistent increase in plasma FSH during CR in female, but not 
male, mice independent of genotype. It is possible that this increase with CR allows the N-OX 
mice to leave estrus and reenter the estrous cycle before arresting in the next diestrus. The origin 
of this increase in FSH is not known but we observed a significant increase in pituitary Fshb 
mRNA in the N-OX mice with CR. Interestingly, loss of SIRT1 has been implicated in increased 
Fshb production by pituitary gonadotropes61. We also observed increases in hypothalamic Npy 
and Agrp mRNAs in the N-OX mice on CR, which may underlie the effects of caloric restriction 
as they inhibit GnRH neurons to suppress reproductive cycles.  
Lastly, SIRT1 has also been implicated in circadian rhythms in the suprachiasmatic nucleus54 
and in relaying nutritional inputs to the clock via Sf1 neurons in the VMH62. The total brain 
SIRT1 knockout has increased photoperiod, and the SIRT1 overexpressors have decreased 
photoperiod compared to WT controls54. In our study, neither N-OX nor N-MUT mice 
demonstrated a circadian phenotype but it is possible that the synapsin-cre does not express in 
SCN neurons although synapsin 1 is a reliable marker for synapse formation in the SCN63. 
Further studies will be needed to resolve this discrepancy. 
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Figure 1: Neuronal SIRT1 causes glucose intolerance.  For all figures N-MUT mice are 
shown in red, wild-type littermates in white, and N-OX mice in green. A. Body weights for male 
mice from 3 weeks to 13 weeks of age (n=13 for N-MUT, n=48 for WT, n=24 for N-OX). 2-way 
ANOVA indicates significant genotype and time effects (p<0.0001) but no interaction. Inset 
shows final body weight at 8-9 months. B. Body weights for female mice from 3 weeks to 13 
weeks of age (n=10 for N-MUT, n=44 for WT, n=20 for N-OX). 2-way ANOVA indicates 
significant genotype and time effects (p<0.0001) but no interaction. Inset shows final body 
weight at 8-9 months. C.  Glucose tolerance test performed in male mice at 3 months of age (n=8 
for N-OX, n=16 for WT, n=4 for N-MUT). 2-way ANOVA indicates significant genotype and 
time effects (p<0.0001) and interaction (p=0.005). Inset shows area under the curve. D. Glucose 
tolerance test performed in female mice at 3 months of age (n=9 for N-OX, n=16 for WT, n=6 
for N-MUT). 2-way ANOVA indicates significant genotype and time effects (p<0.0001) but no 
interaction. Inset shows area under the curve. E. Insulin tolerance test performed in male mice at 
3 months of age (n=9 for N-OX, n=16 for WT, n=6 for N-MUT). 2-way ANOVA indicates 
significant genotype and time effects (p<0.01 and p<0.0001) but no interaction. F. Insulin 
tolerance test performed in female mice at 3 months of age (n=10 for N-OX, n=16 for WT, n=6 
for N-MUT). 2-way ANOVA indicates significant genotype and time effects (p<0.001 and 
p<0.0001) but no interaction. G. Daily food intake over 10 weeks for male mice (n=3 for N-
MUT, n=12 for WT, n=4 for N-OX). H. Daily food intake over 10 weeks for female mice (n=6 
for N-MUT, n=11 for WT, n=5 for N-OX). I. Fasting blood glucose in male mice (n=17 for N-
OX, n=32 for WT, n=8 for N-MUT). J. Fasting blood glucose in female mice (n=20 for N-OX 
n=32 for WT, n=4 for N-MUT). K. Fasting insulin in male mice (n=6 for N-MUT, n=14 for WT, 
n=6 for N-OX). L. Fasting insulin in female mice (n=6 for N-MUT, n=12 for WT, n=6 for N-
OX). M. Fasting leptin in male mice (n=6 for N-MUT, n=14 for WT, n=6 for N-OX). N. Fasting 
leptin in female mice (n=6 for N-MUT, n=12 for WT, n=6 for N-OX). Data shown are mean ± 
SEM. Asterisks report significance vs WT or as indicated; *p<0.05, **p<0.01, *p<0.001, 
****p<0.0001. 
Figure 2: Neuronal SIRT1 regulates reproduction in female mice. Color scheme is same as 
Figure 1. A. Day of vaginal opening (n=8 for N-MUT, n=40 for WT, n=18 for N-OX). B. Day of 
first estrous (n=8 for N-MUT, n=41 for WT, n=21 for N-OX). C. Number of estrous cycles by 
vaginal lavage over 6 weeks (n=6 for N-MUT, n=11 for WT, n=5 for N-OX). D. Cycle length 
during the 6 weeks (n=44 for N-MUT, n=74 for WT, n=19 for N-OX). E. Relative frequency 
histogram of cycle lengths. F. Percentage of days spent in each stage of the estrous cycle during 
the 6-week cycling (n=6 for N-MUT, n=11 for WT, n=5 for N-OX). 2-way ANOVA indicates 
significant stage effect (p<0.0001) and significant interaction of stage and genotype (p<0.0001). 
G. FSH levels during diestrus, the morning of pro-estrus, the afternoon of proestrus, and the 
morning of estrus (n=8 for N-MUT, n=16 for WT, n=8 for N-OX). 2-way ANOVA indicates 
significant stage effect (p=0.015) and significant interaction of stage and genotype (p=0.013). H. 
LH levels during diestrus, the morning of pro-estrus, and the morning of estrus (n=8 for N-MUT, 
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n=16 for WT, n=8 for N-OX). 2-way ANOVA indicates significant stage effect (p=0.013) but no 
interaction of stage and genotype. I. LH levels during the afternoon of proestrus (n=8 for N-
MUT, n=16 for WT, n=8 for N-OX). Proestrus LH values do not follow a normal distribution, so 
N-OX mice have significantly lower LH than WT mice by Kruskal-Wallis test (p=0.033). J. 
Progesterone levels during the afternoon of proestrus (n=7 for WT, n=7 for N-OX). K. Days to 
plug, days to first litter and litter size during fertility test (n=3 for N-MUT, n=11 for WT, n=6 for 
N-OX). Data shown are mean ± SEM. Asterisks report significance vs WT or as indicated; 
*p<0.05, **p<0.01, *p<0.001, ****p<0.0001. 
Figure 3: Overexpression of SIRT1 impairs ovulation. Color scheme is same as Figure 1. A. 
Ovarian morphology. Representative H&E stained sections of ovaries obtained at sacrifice. AF 
indicates antral follicle, CL indicates corpora lutea. B. Quantification of ovarian cross-sectional 
area for N-MUT (n=12), WT (n=15) and N-OX (n=8) ovaries. *p<0.05 v.s. N-MUT. C. 
Quantification of follicle stage. Percentage of follicles at each stage for N-MUT (n=6), WT 
(n=9) and N-OX (n=4) mice. D. Quantification of corpora lutea for N-MUT (n=6), WT (n=9) 
and N-OX (n=4) mice. *p<0.05 v.s. WT. Data are shown as mean ±SEM. Asterisks indicate 
significance by post-hoc testing. 
Figure 4: Overexpression of SIRT1 enhances the metabolic response to caloric restriction. 
Color scheme is same as Figure 1. A.  Glucose tolerance test performed after caloric restriction 
(n=8 for N-OX, n=17 for WT, n=6 for N-MUT, n=20 males, n=11 females). 2-way ANOVA 
indicates significant time effect (p<0.0001) and time-genotype interaction (p=0.0025). B. Fasting 
insulin during CR (n=14 for N-MUT, n=26 for WT, n=12 for N-OX, n=28 males, n=24 females). 
C. Fasting leptin during CR (n=14 for N-MUT, n=26 for WT, n=12 for N-OX, n=28 males, n=24 
females). 2-way ANOVA indicates significant genotype effect (p<0.0001). Data are shown as 
mean ± SEM. Asterisks indicate significant differences between N-OX and WT and N-MUT, or 
as indicated, from post-hoc testing; *p<0.05, **p<0.01. 
Figure 5: Overexpression of SIRT1 enhances the reproductive response to caloric 
restriction. Color scheme is same as Figure 1. Estrous cycles were assessed by vaginal lavage in 
female mice during the eight weeks of caloric restriction.  Data are shown as mean ± SEM. A. 
Average number of days spent in metestrus/diestrus, proestrus or estrus during the four 2-week 
stages of increasing CR (stage 1: before CR; stage 2: weeks 1 & 2, 10-20% restriction; stage 3: 
weeks 3 & 4, 30-40% restriction; and stage 4: weeks 5 & 6, 40% restriction) for each genotype 
of the estrous cycle during the 6-week cycling (n=6 for N-MUT, n=14 for WT, n=5 for N-OX). 
2-way ANOVA indicates significant CR effect (p<0.0001) and significant interaction of CR and 
genotype (p=0.003) for met/diestrus, a CR effect (p<0.0001) for proestrus, and a genotype effect 
(p=0.017), a CR effect (p<0.0001), and a significant interaction of CR and genotype (p=0.011) 
for estrus.  B. LH levels during the four stages of CR (n=6 for N-MUT, n=12 for WT, n=5 for N-
OX). No significant differences were observed. C. FSH levels during the four stages of CR (n=6 
for N-MUT, n=12 for WT, n=5 for N-OX). 2-way ANOVA indicates significant genotype effect 
(p=0.022) and CR effect (p=0.002) but no significant interaction. D, E and F. Estradiol, 
progesterone and testosterone levels before and after CR (n=3 for N-MUT, n=3 for WT, n=3 for 
N-OX, each sample was pooled from two animals). 2-way ANOVA indicates a significant 
genotype effect (p=0.0004) and CR effect (p=0.0033) for estradiol, a CR effect (p=0.0055) for 
progesterone, and a genotype effect (p=0.015) and CR effect (p=0.019) for testosterone.  No 
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significant interactions of CR and genotype were observed. Asterisks indicate significant 
differences as indicated from post-hoc testing; *p<0.05, **p<0.01, *p<0.001, ****p<0.0001. 
Figure 6: Hypothalamic and pituitary gene expression in N-MUT and N-OX mice. Color 
scheme is same as Figure 1. A. Gene expression in the hypothalami from female mice by QPCR. 
B. Gene expression in the pituitaries from female mice by QPCR. Data are shown as mean ± 
SEM, n=5 for N-MUT, n=10 for WT, and n=5 for N-OX. Asterisks indicate statistical 
significance as indicated by ANOVA: *p<0.05, **p<0.01. 
Figure 7: Metabolic cage assessment of N-OX mice. WT mice (n=6) are shown in black and 
N-OX mice (n=6) in green. Graphs show diurnal patterns over 24 h measured per 13 minute 
interval. Horizontal black bar indicates period of lights off (6 pm to 6 am). A. Ambulatory 
activity counts (x-axis). B. Rearing activity counts (z-axis). C. VO2 consumption (ml/kg/h). D. 
Respiratory exchange ratio (RER). E. Food intake (g). F. Water intake (ml). G. Heat produced 
(kcal/h). H. Cage Temperature (˚C). Data are shown as mean ± SEM. In all cases repeated 
measures ANOVA indicated a significant time effect (p<0.0001).  Ambulatory activity, rearing 
activity, VO2, RER, and water intake showed significant genotype effects (p<0.0001, p<0.0001, 
p<0.0001, p=0.0004, and p=0.04, respectively). Asterisks indicate statistical significance by 
post-hoc testing: *p<0.05, **p<0.01. 
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